FDA Updates Saquinavir Labeling
“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir."
“Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.”
The updated labeling will be available at the FDA website.
More information is available:
FDA: Press release
AIDSinfo: Patient fact sheet on saquinavir
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - Category: Infectious Diseases Source Type: news
More News: Department of Health | Health | HIV AIDS | Infectious Diseases | Norvir | Warnings | Websites